PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences

PHAXIAM publie aujourd’hui sa trésorerie au 30 juin 2023 et son calendrier financier pour le second semestre 2023.

Continue ReadingPHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences

ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023

Erytech announced today that all resolutions for which the Board of Directors recommended a vote in favor, including the approval of the merger with Pherecydes, were adopted by its shareholders…

Continue ReadingERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023

ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023

ERYTECH’s shareholders are hereby informed of the Annual General Meeting which will be held on June 23, 2023 at 09:30am CEST at the Hôtel Intercontinental, 2 rue Scribe, 75009 Paris…

Continue ReadingERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023
Menu